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Abstract
Polyamines, including spermine (Spm) and spermidine (Spd), are aliphatic cations that are
reportedly synthesized by all living organisms. They exert pleiotropic effects on cells and are
required for efficient nucleic acid and protein synthesis. Here, we report that the human pathogen
Staphylococcus aureus lacks identifiable polyamine biosynthetic genes, and consequently
produces no Spm/Spd or their precursor compounds putrescine and agmatine. Moreover, while
supplementing defined medium with polyamines generally enhances bacterial growth, Spm and
Spd exert bactericidal effects on S. aureus at physiologic concentrations. Small colony variants
specifically lacking menaquinone biosynthesis arose after prolonged Spm exposure and exhibited
reduced polyamine-sensitivity. However, other respiratory-defective mutants were no less
susceptible to Spm implying menaquinone itself rather than general respiration is required for full
Spm-toxicity. Polyamine hypersensitivity distinguishes S. aureus from other bacteria and is
exhibited by all tested strains save those belonging to the USA-300 group of Community-
Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA). We identified one gene
within the USA-300-specific Arginine Catabolic Mobile Element (ACME) encoding a Spm/Spd
N-acetyltransferase that is necessary and sufficient for polyamine resistance. S. aureus encounters
significant polyamine levels during infection, however the acquisition of ACME encoded speG
allows USA-300 clones to circumvent polyamine-hypersensitivity, a peculiar trait of S. aureus.
Introduction
Infections caused by the Gram-positive bacterium Staphylococcus aureus impose an
enormous healthcare burden worldwide (Diekema et al., 2001, Klevens et al., 2007). S.
aureus infections are notoriously difficult to treat given the highly invasive nature of this
organism combined with its multiple antimicrobial resistance determinants (Chambers &
Deleo, 2009). Since its first identification in the 1960s, Methicillin-Resistant S. aureus
(MRSA) has become endemic in most hospital settings around the developed world (Barrett
et al., 1968, Klevens et al., 2007). It has been estimated that MRSA infections result in
additional annual healthcare costs exceeding £ 3 billion in the UK alone (Cosgrove et al.,
2005, Gould, 2006). However, since the turn of the last century, MRSA has spread beyond
healthcare settings and into the community (i.e. Community Associated MRSA or CA-
MRSA) (DeLeo et al., 2010). CA-MRSA clones are phylogenetically distinct from
traditional hospital associated MRSA (HA-MRSA) strains. Pulsed-field gel electrophoresis
(PFGE) typing has revealed that HA-MRSA clones often belong to USA-100 and USA-200
PFGE types whereas CA-MRSA isolates generally fall into the USA-300, USA-400 or
USA-1000 groupings (McDougal et al., 2003). CA-MRSA first emerged simultaneously in
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western Australia and in the midwestern United States in the 1990s (Centers for Disease
Control and Prevention, 1999, Udo et al., 1993). This original CA-MRSA clone belonged to
the USA-400 PFGE type and spread globally for a decade. Subsequently, a new CA-MRSA
clone has emerged belonging to the USA-300 group. USA-300 clones have spread quickly
around the world replacing USA-400 in most areas and are currently responsible for the vast
majority of CA-MRSA disease (DeLeo et al., 2010, Stemper et al., 2006). In addition to
their hypertransmissibility, USA-300 clones have been demonstrated to be more virulent
than other CA-MRSA and HA-MRSA isolates in modeled infections for reasons that are not
yet clear (Li et al., 2009, Montgomery et al., 2008).
Given the rapid global spread of CA-MRSA, significant research effort has been undertaken
to explain the hypervirulence and hypertransmissibility associated with USA-300 clones.
Complete genome sequences for archetypical USA-400 (MW2) and USA-300 (FPR3757)
clones have been published and have revealed numerous differences that might help explain
the emergence of this new pandemic (Baba et al., 2002, Diep et al., 2006). For instance,
most CA-MRSA clones harbor a phage-encoded Panton-Valentine Leukotoxin (PVL) that
confers hypervirulence in a rabbit lung infection model (Diep et al., 2010). In contrast, HA-
MRSA clones are rarely PVL-positive (Fey et al., 2003). Moreover, CA-MRSA clones
consistently produce higher levels of α-type Phenol-Soluble Modulins (PSMs), small
secreted peptides with chemoattractant and leukocidal activities, than do HA-MRSA isolates
(Wang et al., 2007). However, both PVL- and elevated αPSM-production are conserved
among CA-MRSA isolates belonging to both USA-400 and USA-300 groupings. Therefore,
these factors are unlikely to explain the dominance of USA-300 clones in most regions of
the developed world. A distinguishing feature of USA-300 genomes compared with other
CA-MRSA isolates is the presence of an Arginine Catabolic Mobile Element (ACME) (Diep
et al., 2006). This 33-gene island is juxtaposed to the SCCmecIVa cassette in virtually all
USA-300 clones (Diep et al., 2008, Goering et al., 2007). The island encodes an arginine
deiminase system, an oligopeptide transporter, various transposases and integrases, as well
as an uncharacterized alcohol dehydrogenase and acetyl-transferase. ACME has been shown
to directly enhance virulence in a rabbit model of bacteremia and is strongly associated with
USA-300 clones but rarely found in any other CA-MRSA or HA-MRSA isolates (Diep et
al., 2008). However, neither the molecular mechanism(s) nor the extent to which ACME
confers an advantage to USA-300 has been clearly established.
Polyamines are aliphatic compounds consisting of at least two primary amino groups.
Generally, the term “polyamine” refers to a group of compounds including putrescine,
agmatine, spermidine and spermine that are all synthesized from L-arginine. Additionally,
diamine compounds such as cadaverine and histamine, which are decarboxylated lysine and
histidine, respectively, are also referred to as polyamines. The synthesis of L-arginine-
dependent polyamines differs among organisms, but is regarded as being present in one
form or another in all living cells (Hamana & Matsuzaki, 1992, Tabor & Tabor, 1985,
Cohen, 2000). For instance, mammals express arginases that convert L-arginine to L-
ornithine, which is subsequently decarboxylated to produce putrescine (Figure 1). Putrescine
is converted to spermidine and then spermine by sequential addition of aminopropyl groups
derived from decarboxylated S-adenosylmethionine. In bacteria, arginase is not common and
spermine is rarely synthesized. Rather, most species first decarboxylate L-arginine to
produce agmatine (Figure 1). Agmatine can then be ureohydrolyzed directly to putrescine or
alternatively, agmatine can be deaminated/decarboxylated through N-carbamoylputrescine
to produce putrescine. The variety of pathways dedicated to the synthesis of these important
biological compounds implies convergent evolution with some enzymatic steps
independently evolving three distinct times in animals, fungi and plants (Hamana &
Matsuzaki, 1992, Minguet et al., 2008).
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In general polyamines exert pleiotropic effects on the basic cellular physiology of all
organisms, from archaea to animals and plants. In contrast to metal cations, polyamines
distribute their positive charges along a flexible hydrocarbon backbone. Thus, they are ideal
for dissipating repulsive forces exerted between negatively charged nucleic acids and protein
surfaces. Indeed, intracellular polyamines are abundantly bound to ribosomes, chromatin
and mRNA and this binding facilitates macromolecular synthesis (Cohen, 2000). Moreover,
increased polyamine synthesis is well documented in rapidly dividing tissues undergoing
high rates of nucleic acid synthesis such as during embryogenesis, tumorigenesis, wound
healing and inflammation (Moinard et al., 2005, Seiler & Atanassov, 1994, Thomas &
Thomas, 2001). Interestingly, polyamine production is also associated with modulating
inflammation by a variety of transcriptional and post-transcriptional mechanisms (Seiler &
Atanassov, 1994, Zhang et al., 2000). In bacteria, exogenous polyamine supplementation
promotes replication for many of the same reasons outlined above. Additionally, polyamines
have been shown to affect specific gene expression in bacteria by binding to mRNA and
tRNA structural elements (Igarashi & Kashiwagi, 2000, Shah & Swiatlo, 2008). They have
also been implicated in modulating outer membrane permeability through interactions with
porin proteins and can act as non-specific antioxidants in aerobically cultured bacteria (Iyer
et al., 2000, Ha et al., 1998, Khan et al., 1992). Given the plethora of functions attributed to
polyamines, their synthesis represents a conserved feature across all three kingdoms of life.
Here we report the absence of de novo polyamine production by the human pathogen S.
aureus. More importantly, we show that exogenous polyamines inhibit rather than enhance
S. aureus growth and that they can be bactericidal at concentrations known to exist within
the human host (Zhang et al., 2000). During growth within inflamed tissue, S. aureus likely
encounters significant polyamine levels, which may act to specifically limit S. aureus
proliferation to some extent. This unique polyamine hypersensitivity is inherent to nearly all
tested strains of S. aureus and distinguishes this species from nearly all life on earth. The
only notable exceptions are clones belonging to the newly emerged USA-300 CA-MRSA
group. USA-300 strains exhibit complete resistance to high levels of exogenous polyamines,
and we show here that this polyamine-resistant phenotype depends on the presence of a
spermine/spermidine acetyl-transferase encoded within the ACME island. Thus, the
acquisition of ACME by USA-300 isolates resulted in complete resistance to physiologic
polyamine concentrations and may represent a selective advantage that explains the
dominance of these clones in CA-MRSA disease today.
Results
S. aureus lacks de novo polyamine synthesis
Bacteria can synthesize polyamines from L-arginine through agmatine and/or L-ornithine by a
variety of pathways (Figure 1). Inspection of thirteen staphylococcal genomes revealed no
homologues to SAM-decarboxylase or spermidine synthase suggesting that S. aureus cannot
produce spermidine from putrescine. The only putative polyamine biosynthetic enzyme
encoded by S. aureus (SACOL0523) belongs to the family of aspartate amino-transferases,
which include ornithine/arginine/lysine decarboxylases that catalyze the formation of
putrescine/agmatine/cadaverine depending on substrate specificity. Thus, the polyamine
biosynthetic capabilities of S. aureus are limited to potentially one species from this
ubiquitous family of compounds. Larger phylogenetic analyses revealed that many gram-
positive bacteria and a few gram-negative species also lack de novo polyamine synthesis
(Figure S1). Indeed, Streptococcus pyogenes and S. agalactiae lack identifiable biosynthetic
homologues, while S. pneumonia, an organism known to make polyamines, has a complete
biosynthetic pathway (Shah et al., 2011). Similarly, Enterococci, Lactococci, Haemophilus
ssp., Borrellia spp., certain species of Francisella and Mollicutes such as Mycoplasma and
Ureaplasma spp. lack genes encoding de novo polyamine synthesis as well (Figure S1). We
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sought to determine whether these compounds were indeed synthesized de novo by some of
these organisms implying new pathways exist for the production of polyamines.
Accordingly, we assayed for de novo polyamine production by a number of bacterial species
cultivated in chemically defined medium devoid of exogenous polyamines (Table 1). In
contrast to E. coli, B. subtilis, and P. aeruginosa, organisms known to produce polyamines
de novo, whole-cell extracts of S. aureus lacked detectible levels of any tested polyamine
species (Figure S2 and Table 1). E. coli and B. subtilis preferentially produce the L-arginine-
derived polyamines spermidine and putrescine, while P. aeruginosa additionally produced
large amounts of cadaverine, a lysine-derived polyamine (Table 1). The lack of any
detectible polyamine species in S. aureus confirms predictions from genomic inspection.
Moreover, S. agalactiae strain A909 also produced no detectible polyamines when
cultivated in broth culture, again underscoring the lack of predicted biosynthetic pathways in
many streptococcal genomes (data not shown). Curiously, F. novicida seems to have lost a
genetic island retained by F. tularensis subspecies holarctica and tularensis that is required
for the synthesis of L-arginine-derived polyamines. In line with this prediction, F. tularensis
holarctica strain LVS produced high levels of spermidine, putrescine and agmatine, while
none of these were detected in F. novicida (data not shown). Overall, these data are in direct
conflict with the dogma that all living organisms synthesize polyamines, and S. aureus is not
alone as an organism devoid of de novo polyamine biosynthesis.
S. aureus exhibits hypersensitivity towards exogenous spermine/spermidine
Addition of 1mM spermine or spermidine to synthetic medium devoid of polyamines
generally enhanced the growth of E. coli and B. subtilis but severely limited the growth of S.
aureus (data not shown). Polyamine sensitivity was assessed here by measuring the zone of
inhibition surrounding a sterile filter disk impregnated with 250 mM of a particular
polyamine species (Figure 2A). In contrast to other Gram-positive and Gram-negative
species, S. aureus is highly sensitive to spermine (Figure 2A) and spermidine (Figure S3),
but not putrescine, agmatine or cadaverine (data not shown). While spermine concentrations
at this level can significantly raise the media pH, no inhibition zone was observed in S.
aureus around discs supplemented with 250 mM NaOH suggesting that spermine toxicity is
not mediated through alkaline stress (data not shown). Spermine MIC values were
consistently ~2 mM among sensitive S. aureus strains, but were > 10 mM for other species
(e.g. B. subtilis, L. monocytogenes, E. coli, S. Typhimurium, or P. aeruginosa). Spermine
was bactericidal at levels ≥ 3 mM and exposure to 5 mM spermine exerted 2-logs of killing
within 3 h of exposure and > 3-logs killing after 24 h (Figure 2B). Spermidine also exhibited
bactericidal activity albeit at higher concentrations (MIC/MBC levels ≥ 10-fold above
spermine, above levels likely encountered in host tissue). The toxicity of polyamines
towards S. aureus was more pronounced with increasing pH as previously observed
(Rozansky et al., 1954). At neutral pH and above, clear zones of inhibition could be detected
around spermine discs, however acidifying the polyamine solution below neutrality
abrogated toxicity towards S. aureus (Figure S4A). Thus, polyamine toxicity towards S.
aureus is inversely proportional to the net cationic charge of polyamines since they become
sequentially deprotonated at elevated pH.
Considering that S. aureus is not the only bacterial species unable to synthesize polyamines,
we tested whether the lack of de novo synthesis correlated with polyamine sensitivity.
Gram-negative F. novicida, H. influenzae and H. ducreyi do not encode polyamine synthetic
pathways and the lack of polyamine production in F. novicida was experimentally verified,
yet none of these species exhibited heightened sensitivity to spermine (data not shown). In
contrast, both group A and B streptococci were sensitive to exogenous spermine and
spermidine to levels similarly observed in staphylococci (Figure S3). Thus, lacking de novo
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polyamine synthesis and hypersensitivity to spermine/spermidine are unrelated traits with
hypersensitivity being associated with specific Gram-positive pathogens including S. aureus.
S. aureus polyamine-sensitivity requires menadione biosynthesis but is independent of
respiration
To gain insights into the mechanism(s) underlying S. aureus polyamine sensitivity, we
isolated spontaneous mutants exhibiting increased spermine resistance compared with
parental WT strain Newman. Plating ~ 1 × 109 cfu of S. aureus strain Newman onto BHI
agar supplemented with 20 mM spermine resulted in the appearance of small, non-
pigmented colonies arising within 48 to 72 h at a frequency of ~1 × 10−6·plated cfu−1.
Forty-two out of the 47 (89%) isolated colonies were stable, slow-growing, non-pigmented
small colony variants (SCVs) that exhibited reduced spermine sensitivity when assayed via
disc diffusion (Figure 3). These spermine-resistant SCVs were exposed to exogenous
menadione, hemin, thiamine or thymidine to determine the nature of the mutation that
generated the SCV phenotype. All but 7 exhibited restored growth and pigmentation when
supplemented with exogenous menadione, while the remaining strains were not rescued by
any of the four supplements (Figure 3A). Moreover, supplementation of these SCVs with
exogenous menadione also restored full spermine toxicity (data not shown). Consistently,
insertional inactivation of menD, which exhibits typical SCV phenotypes, resulted in an
elevation of spermine MIC and MBC that could be reversed by the addition of exogenous
menadione (Table 2 and Figures 3B and 3C). As menaquinone is the sole quinone electron
carrier species in S. aureus, loss of de novo biosynthesis would result in cells unable to
respire. Accordingly, spermine disc diffusion zones and MIC levels were determined for S.
aureus cultured anaerobically demonstrating that without oxygen, spermine exerts reduced
toxicity towards S. aureus strains COL and Newman (Table 2).
However, several pieces of data argue against respiration in general as being required for
full spermine toxicity but rather menaquione itself is necessary for the cytotoxic effects of
spermine on S. aureus. First, supplementing anaerobic cultures with 20 mM nitrate to
promote anaerobic respiration did not restore any spermine-toxicity (Table 2). Moreover,
menD::ErR strains exhibit increased spermine resistance anaerobically in the absence of
respiration (Table 2). Finally, a ΔhemB mutant, an SCV that also lacks respiratory activity,
was still susceptible to spermine (Figure 3B). The fact that spermine toxicity in S. aureus
does not require respiration per se but is dependent on the presence of menaquinone is
consistent with the fact that of all the know genetic etiologies responsible for S. aureus SCV
phenotypes, menaquinone auxotrophy was most commonly isolated variant with heightened
spermine resistance. We also addressed whether slow growing cells in general, which are
often difficult to kill with bactericidal agents, exhibit reduced susceptibility to spermine.
Decreasing incubation temperatures slows the growth of S. aureus yet spermine becomes
increasingly toxic at these lower temperatures (Figure S4). Thus, the presence of
menaquinone itself is necessary for full spermine sensitivity, but not necessarily due to its
role in respiration or in achieving maximal growth rates.
USA-300 clones of S. aureus resist polyamine cytotoxicity by expressing a predicted
spermine/spermidine acetyltransferase harbored on the ACME island
In contrast to other S. aureus strains, USA-300 clones, including SF8300 and LAC, exhibit
innate resistance to spermine and spermidine (Figures 2A and S3). This phenotype differs
significantly with the spontaneously occurring menadione-auxotrophic SCVs in that
USA-300 clones are fully pigmented and fast growing. Furthermore, supplementation with
exogenous menadione did not confer polyamine-sensitivity to USA-300 clones (data not
shown). However, an SF8300 derivative with a deletion encompassing the entire ACME
island exhibited typical S. aureus polyamine sensitivity (Figures 2A and 4). The ACME
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island is a 33-gene composite element with regions of genetic synteny conserved in other
coagulase negative staphylococci (Figure 4). One gene within ACME, SAUSA300_0053,
encodes a predicted GNAT family acetyltransferase with homology to SpeG from E. coli, an
N-1 spermidine acetyltransferase (51%/71% identical/similar). ΔspeG USA-300 exhibited
full spermine/spermidine sensitivity as determined in both SF8300 and LAC (Figures 4 and
S3). Moreover, providing speG in trans complements the polyamine sensitivity of both the
ΔACME and ΔspeG mutants (Figures 4 and S3). Finally, expressing speG in non-USA-300
clones such as S. aureus COL or Newman provides complete polyamine resistance to these
otherwise sensitive strains (Figures 4 and S3). Thus, ACME encoded speG is necessary and
sufficient for polyamine resistance in USA300 S. aureus.
To assess whether the acetyltransferase activity of SpeG was responsible for conferring
polyamine resistance, we employed the antitrypanosomal agent Berenil, which is known to
inhibit human spermine/spermidine acetyltransferase (SSAT) activity (Libby & Porter,
1992). Mammals acetylate spermine and spermidine to sequentially convert them back to
putrescine in order to maintain polyamine homeostasis. Human SSAT is therefore the
mammalian equivalent of bacterial SpeG either of which should be inhibited by an
acetyltransferase inhibitor such as Berenil. Administering Berenil inhibited the growth of
USA300 in the presence of 5 mM spermine in a dose dependent fashion, consistent with the
compound’s role as a spermine/spermidine acetyltransferase inhibitor (Figure 5). In contrast,
Berenil was not detrimental to the growth of USA300 S. aureus in the absence of exogenous
polyamines (Figure 5). Thus, SpeG SSAT-activity is required for USA300 polyamine
resistance. To test whether the product of SpeG, mono-acetylated spermine, is sufficient to
eliminate its toxicity towards S. aureus, polyamine sensitive S. aureus Newman was
exposed to exogenous N-1-acetylspermine. Acetylated spermine had no effect on the growth
of S. aureus (Figure S5) supporting the notion that toxicity is not correlated with net
polyamine charge since both nontoxic N-1-acetylspermine and toxic spermidine have the
same net +3 charge.
Q-RT PCR analysis revealed that the speG transcript is abundant in USA-300 clones and
constitutively expressed throughout all stages of growth. Additionally, high-level expression
is independent of the presence or absence of exogenous spermine (Figure S6).
Discussion
The assertion that polyamines constitute a class of essential compounds synthesized by all
living organisms has been directly challenged here. The fact that entire genera of unrelated
bacteria seem to lack biosynthetic genes implies that the requirement for polyamine
biosynthesis has been lost several times over the course of bacterial evolution. Indeed,
species with “streamlined” genomes including Mycoplasma, Ureaplasma and Haemophilus
universally lack any homologues to polyamine biosynthetic genes. Moreover, organisms
with “larger” genomes can be identified that also lack de novo polyamine synthesis
including F. novicida, Borrelia ssp., and various species of the Lactobacilliales (e.g. S.
pyogenes, S. agalacticiae, E. faecalis and certain strains of L. lactis). Some of these
organisms may still require polyamine import from their mammalian hosts making them true
“polyamine auxotrophs”. This is inline with our data that while H. influenzae, H. ducreyi
and F. novicida lack polyamine biosynthesis, they exhibit no growth inhibition in the
presence of exogenous spermine or spermidine. In fact, Chamberlain’s defined media for
Francisella cultivation calls for supplementation with spermine (Chamberlain, 1965). Thus,
it would appear that “polyamine auxotrophy” is a naturally occurring phenomenon though it
is limited to select bacterial species. In contrast to true “polyamine auxtrophs”, S. aureus
lacks de novo polyamine synthesis but grows quite well in their absence. In fact, exogenous
spermidine and spermine are highly toxic to S. aureus. Taken together, these data imply that
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S. aureus is not a true “polyamine-auxotroph”, but rather has evolved “polyamine-
independence”, a remarkable evolutionary feat given the wide range of biological roles
assigned to these molecules.
The complete absence of detectible polyamine production by S. aureus cultured in
chemically defined medium was unexpected given the presence of a putative ornithine/
arginine/lysine decarboxylase (SACOL0523) encoded in the S. aureus genome. We assessed
polyamine levels in multiple S. aureus strains, thus it is unlikely that this enzyme happened
to be inactive in our chosen isolate (data not shown). Rather, SACOL0523 may not be
expressed under our laboratory conditions, though similar enzymes from other organisms
are highly expressed in media lacking exogenous polyamines resulting in abundant de novo
synthesis (Table 1 and Figure S2). Alternatively, it is possible that the product of this
enzyme (putrescine, agmatine, or cadaverine) is an intermediate consumed by a downstream
reaction such that steady-state levels are below our limit of detection. Another explanation is
that SACOL0523 is misannotated and is merely an aspartate aminotransferase family
member other than an Orn/Arg/Lys decarboxylase. In any case, under conditions where
most bacterial species synthesize copious amounts of polyamines, S. aureus produces none
to detectible levels.
Here we also show that, in addition to the lack of robust polyamine production in S. aureus,
this species is hypersensitive to their presence in the environment (Figure 2). This
observation was first reported over fifty years ago in a study that found staphylococcal ssp.
to be significantly more sensitive to spermine than other tested bacteria (Rozansky et al.,
1954). In a follow-up study, this same group showed that S. aureus spermine hyper-
sensitivity was apparent under both aerobic and anaerobic conditions as long as the bacteria
were metabolically active (Grossowicz et al., 1955). However, these studies used bacteria
plated on solid media, then incubated in anaerobic jars. We also observe significant
inhibition zones around spermine discs in anaerobic jars (data not shown), but when cultured
under true anaerobiosis no zones of inhibition are apparent along with significant increases
in MIC values in liquid culture (Table 2). Given the kinetics of spermine-induced killing
(Figure 2), it is likely that significant killing occurs in anaerobe jars prior to achieving true
anoxia. We therefore maintain that the absence of oxygen significantly curtails the
bactericidal activity of spermine towards S. aureus.
The metabolic state of S. aureus, whether fermenting or respiring, does not directly correlate
with spermine toxicity. First, S. aureus respiring anaerobically on nitrate are no more
sensitive to spermine than are fermenting cells (Table 2). Second, different mutants unable
to respire aerobically exhibit differential spermine susceptibility. Namely, menD mutants
exhibit decreased spermine-sensitivity while ΔhemB mutants do not. This explains why of
all SCV etiologies, menaquinone auxotrophy was most commonly isolated in mutants with
heightened spermine-resistance. This cannot be attributed to the specific absence of
menaquinone in BHI medium compared with other known SCV auxotrophies including
heme, thiamine or thymidine. For example, ΔhemB mutants still require heme
supplementation to BHI for normal growth and pigmentation, thus heme levels in BHI are
not high enough to completely rescue full heme-auxotrophy. Therefore, if heme-auxotrophy
led to increased spermine-resistance, these mutants should have been isolated even on BHI
medium. It seems as though spermine toxicity is mediated by menaquinone rather than by
menaquinone-dependent respiration per se, both aerobically and anaerobically (Figure 3 and
Table 2). However, it is clear that oxygen potentiates spermine toxicity towards S. aureus.
Previous studies on the antibacterial effects of spermine on S. aureus were all carried out
prior to the emergence of USA-300 or MRSA in general, thus highly resistant S. aureus
were never observed. The recent acquisition of ACME by CA-MRSA represents one of the
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most distinguishing features of USA-300. Virtually all tested USA-300 strains harboring the
SCCmec IVa cassette also carried ACME (Diep et al., 2008, Goering et al., 2007). Only
USA-300 clones carrying other SCCmec cassettes (~10% of USA-300 isolates) lack
detectible ACME sequences (Goering et al., 2007). Thus, the predominant CA-MRSA
lineage causing disease today is almost universally ACME positive, and consequently, likely
resistant to exogenous spermine/spermidine. Whether this polyamine-resistance plays a role
in S. aureus virulence, and therefore contributes to the success of the USA-300 lineage has
yet to be demonstrated. The presence of ACME has been associated with virulence in a
rabbit sepsis model, but not in murine sepsis or wound-healing models (Diep et al., 2008,
Montgomery et al., 2009). However, the role for ACME, and particularly speG, in CA-
MRSA virulence may be subtle and therefore difficult to assess in acute infection models.
ACME entered into a clinically relevant clonal complex known as CC8 (Li et al., 2009,
Tenover & Goering, 2009). Therefore, it’s quite possible that ACME merely contributes to
as opposed to constituting virulence in an already established invasive clone.
Interestingly, ACME was acquired by USA-300 from S. epidermidis where it can be
detected in half of all isolates (Miragaia et al., 2009). Whereas, significant diversity exists
among ACME islands from S. epidermidis, the most common form (ACME-1.02) is
identical to the island found in USA-300 S. aureus and encodes a speG (Miragaia et al.,
2009). Consequently, only two out of six tested S. epidermidis isolates proved sensitive to
spermine/spermidine implying that speG is more common among S. epidermidis (Figure
S3). In addition, we found a S. saprophyticus clone that was also completely resistant to
spermine, underscoring the extent to which this phenotype has spread among staphylococci.
In fact, recent studies have identified a plasmid-borne ornithine decarboxylase catalyzing
putrescine production in rare strains of S. epidermidis (Coton et al., 2010). Thus,
“polyamine independence” may be eventually lost to this genus of human commensals/
pathogens.
Here we have demonstrated that the spermine/spermidine-acetyltransferase activity of
ACME encoded SpeG affords USA-300 clones with complete resistance to
antistaphylococcal polyamines. It is unclear how acetylation of polyamines abolishes their
toxicity towards S. aureus. In contrast to the membrane associated BltD spermidine-
acetyltransferase of B. subtilis, SpeG from E. coli is a cytosolic protein as is predicted of
ACME encoded SpeG (Fukuchi et al., 1994, Woolridge et al., 1999). This is consistent with
an intracellular spermine target that is unreactive with N-acetylspermine. While polyamine
acetylation does decrease the overall positive charge associated with these molecules, this
alone cannot account for the protective effect of acetylation. First, non-toxic N-1
acetylspermine has the same net +3 charge as unmodified spermidine, but the latter is still
bactericidal to S. aureus. Second, polyamines exert greater toxicity at high pH (Figure S4) at
which their net positive charge is diminished through deprotonization (Rozansky et al.,
1954). Rather, our data fit within a hypothetical model whereby rapid import of spermine/
spermidine leads to their menaquinone-dependent enzymatic modification into toxic
intermediates, a process that is inhibited by SpeG-mediated acetylation and less pronounced
in the absence of oxygen. Interestingly, a menD mutant was more resistant than WT to
spermine even under anaerobiosis (Table 2). This may indicate that in complex medium
(Brain Heart Infusion) there are metabolites that allow S. aureus to oxidize low levels of
menaquinone that can be used to toxify spermine. However, the nature of these electron
acceptor(s) is currently undefined. Alternatively, menaquinone may act directly with
spermine at membrane interfaces and cells still synthesize reduced levels of menaquinone
anaerobically. More work is required to fully understand the mechanism of S. aureus
spermine toxicity.
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Growing within inflamed tissue, S. aureus must contend with increased polyamine
production from the reported stimulation of host biosynthetic enzymes (Seiler & Atanassov,
1994, Zhang et al., 2000). Acquisition of ACME and SpeG by CA-MRSA represents an
adaptation to this environment and may help to explain the extreme success of USA-300
clones.
Experimental Procedures
Bacterial Strains and Culture Conditions
Strains used in this work are listed in Table S1. Bacteria were generally cultivated in Brain
Heart Infusion Broth/Agar (Difco, Detroit, MI) or chemically defined PN media (Pattee and
Neveln, 1975) in shaking cultures (250 rpm) at 37° C. The only exceptions were Francisella
strains were cultivated in Chamberlain’s chemically defined medium lacking spermine
supplementation, Haemophilus species were grown on chocolate agar plates and
streptococci were cultivated in standing BHI cultures. For cloning purposes, E. coli strain
DH10B was routinely grown in LB medium. Media were supplemented with antibiotics
when appropriate: ampicillin (E. coli 100 µg·ml−1), chloramphenicol (S. aureus 20
µg·ml−1), erythromycin (E. coli 300 µg·ml−1, S. aureus 5 µg·ml−1) or spectinomycin (S.
aureus 500 µg·ml−1, E. coli 100 µg·ml−1). To achieve anaerobiosis, cells were either
incubated at 37° C in anaerobe jars with GasPak™ EZ catalyst system (Becton Dickenson,
Franklin Lakes, NJ) or in an anaerobe chamber under a N2/CO2/H2 (90%/5%/5%)
atmosphere (Coy Laboratory Products, Inc., Grass Lakes, MI).
ΔspeG was constructed using allelic exchange to insert an unmarked, in-frame deletion
allele into the SF8300 chromsome. ~1 kb 5’ and 3’ homology fragments were amplified
using primers listed in Table S2, then linked using Splicing Overlapping Extension
(SOEing) PCR. The resulting fragment was cloned into an E. coli/S. aureus shuttle vector
(pBT2ts), and allelic exchange was performed as previously described (Richardson et al.,
2006, Bruckner, 1997). ΔhemB::SpR mutants were constructed by cloning ~1kb 5’ and 3’
flanking homology regions on either side of a SpR cassette cloned into an E. coli/S. aureus
shuttle vector (pBT2ts). Allelic exchange was then performed as previously described
(Richardson et al., 2006). menD::ErR mutants were generated by amplifying the menD locus
with primers listed in Table S1 and cloning into pCR Blunt II Topo cloning vector
(Invitrogen, Carlsbad, CA). A ErR cassette from Tn1545 was inserted into a blunted unique
NdeI site within menD and the menD::ErR construct was moved into pBT2ts for allelic
exchange.
Determination of Polyamine Inhibition Zones
Bacterial strains were grown overnight from frozen stocks at 37° C in BHI broth. Cultures
were washed and resuspended in 1 ml PBS to cell density of ~1 × 107 CFU·mL−1. BHI agar
plates (with/without 8 µg·ml−1 menadione) were inoculated by spreading 200µl of re-
suspended cells then adding 6mm sterile discs (Becton Dickinson, Sparks, MD)
supplemented with 20µl of 250mM Spermidine, Spermine, Cadaverine, Agmatine,
Putrescine, N1 acetylspermine or NaOH (Sigma Aldrich, St Louis, MO). When appropriate,
the pH of the polyamine free base solutions was adjusted with 1 N HCl. Plates were then
incubated at 4° C, 25°C, 30 °C, 37°C or 42 °C and zone radii were measured after 24 hours
of incubation.
Determination of Spermine Minimum Inihibitory (MIC) and Minimum Bactericidal
Concentration (MBC)
Spermine MIC was determined by inoculating brain heart infusion (BHI) broth containing
various dilutions of spermine (free base) with 1×105 cfu of S. aureus under both aerobic and
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anaerobic conditions. Anaerobic cultures were additionally supplemented with 20 mM
nitrate to allow for anaerobic respiration. The MIC was defined as the lowest concentration
of spermine that prevented growth after incubation for 18h at 37° C. Spermine MBC was
determined by plating wells lacking discernable overnight growth to identify the
concentration of spermine that reduced viability by ≥ 3-logs over 24 h.
HPLC Analysis of Polyamines
All chemicals, reagents and buffers were purchased through Sigma Aldrich (St. Louis, MO).
Bacterial strains were grown overnight from frozen stocks at 37° C in chemically defined
PN or Chamberlain’s media. Cultures were then diluted 1:100 in 20 mL fresh PN/
Chamberlain’s media (Chamberlain, 1965) and allowed to grow to a cell density of ~1.0 ×
109 CFU·mL−1. Cultures were centrifuged, washed and re-suspended in 1 ml PBS. Whole
cell extracts were generated by TCA precipitation followed by centrifugation at 12,000 × g
for 5 minutes. Whole cell extracts were derivatized with benzoyl chloride as previously
described (Morgan, 1998). Derivatized polyamines were then chloroform extracted,
evaporated to dryness, re-suspended in HPLC grade H2O to rehydrate any anhydrous
methylbenzoate, then re-extracted with chloroform. The organic extract was washed 3 times
with HPLC grade H2O, evaporated to dryness and re-suspended in 200µL mobile phase
(15% acetonitrile/0.05% triflouroacetic acid).
50µL samples were injected (Applied Biosystems 112A oven/injector) into an Applied
Biosystems 140B solvent delivery system and monitored using an Applied Biosystems 785A
programmable detection system at 229 nm. Polyamines were separated on a reverse phase
Ambershchrom Resin, CG-300S column, 4.6 × 150 mm (Rohn & Haas, Philadelphia, PA)
and eluted with a 20 minute linear gradient of mobile phase (15% to 75% acetonitrile) with a
flow rate of 0.4 mL·minute−1. Values were analyzed with a Peaksimple Chromatography
Data System (SRI, Torrance, CA). Standard polyamine concentration curves were generated
using derivatized putrescence dihydrochloride, spermidine trihydrochloride, spermine
tetrahydrochloride, N1 acetylspermine trihydrochloride, agmatine sulfate and cadaverine
dihydrochloride (Sigma-Aldrich, St. Louis, MO) analyzed by the above stated method.
RNA isolation and real time analysis
RNA was isolated from three independent cultures of USA 300 (SF8300) at various stages
of growth with/without exogenous spermine (5mM) as described previously (Richardson et
al 2006). Real-time PCR analysis was performed on the iCycler (Bio-Rad Laboratories)
thermocycler. Standard curves with known amounts of genomic DNA were used to
determine primer-pair efficiencies using SensiMix™ SYBR (Quantace). Then, using the
Fluorescein One-Step kit (Quantace), quantitative transcript levels for both rpoD and speG
could be determined in all RNA samples. speG transcript levels were then reported relative
to rpoD levels.
Bioinformatics
To ascertain the presence/absence of polyamine synthetic genes across all published
genomes, the polyamine subsystem of the SEED (http://theseed.uchicago.edu/FIG/index.cgi)
was analyzed (Overbeek et al., 2005).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Arginine-dependent polyamine biosynthetic pathways
Four different biosynthetic pathways exist across all three kingdoms of life for the
conversion of L-arginine to putrescine. Putrescine is then converted to spermidine through
the addition of an aminopropyl group from decarboxylated S-adenosylmethionine (DeC-
AdoMet). Glyphs in the lower right depict pathways present in E. coli as well as humans,
green lines indicate enzymes in the above scheme that are present, red = absent.
Abbreviations: ARG (Arginase), ODC (Ornithine decarboxylase), SPS (Spermidine
synthase), S-MeAd (S-methyladenosine), SDC (S-adenosylmethionine decarboxylase), S-
AdoMet (S-adenosylmethionine), ADC (Arginine decarboxylase), AUH (Agmatine
ureohydrolase, Agmatinase), CPA (N-Carbamoylputrescine amidohydrolase) and PTC
(Putrescine transcarbamoylase).
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Figure 2. Bactericidal effects of spermine on S. aureus
A. Zones of inhibition around discs supplemented with 20 µl of 250 mM spermine across
various species and S. aureus strains. (*) denotes mean zone radii significantly (p ≤ 0.01, n
≥ 3) smaller than that of S. aureus COL (Students t-test). None of these strains exhibited
zones around discs supplemented with 20 µl of 250 mM NaOH. B. Viable cfu of S. aureus
strain COL over a 24-hour exposure to 5 mM Spermine.
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Figure 3. Spontaneous spermine-resistance results primarily in menadione-requiring small
colony variants (SCVs)
A. Proportions of 47 characterized spontaneous spermine-resistant clones that were SCVs
(89%) versus mutants exhibiting normal growth (11%). Normal growth could be restored to
83% of these SCVs by supplementing 8 µg·ml−1 of menadione. The remaining strains were
not rescued by supplementing menadione, heme, thiamine or thymidine. Spermine-resistant
mutants were isolated by plating 109 cfu of S. aureus strain Newman on BHI plates
supplemented with 20 mM Spermine. B. Zones of inhibition around 250 mM spermine discs
using S. aureus strain Newman and isogenic SCV mutants; menD::ErR and ΔhemB. (*)
indicates that the only spermine zone of the menD::ErR mutant was significantly smaller
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than that observed in WT (p ≤ 0.05, n ≥ 3, Student’s t-test) C. Supplementing BHI medium
with 8 µg·ml−1 menadione restored WT growth, normal pigmentation and full spermine
susceptibility to a menD::ErR mutant of S. aureus strain Newman.
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Figure 4. CA-MRSA isolates belonging to the USA-300 PFGE-type exhibit full spermine
resistance due to an ACME encoded spermine/spermidine acetyltransferase (speG)
TOP: Schematic of the 33 gene ACME island found in nearly every USA-300 clone
harboring the SCCMEC type IVa. BOTTOM: speG is necessary and sufficient for USA300
spermine-resistance. Spermine inhibition zones of USA-300 strain SF8300 and isogenic
ΔACME and ΔspeG strains as well as MRSA isolate COL and ΔACME harboring a
plasmid-borne speG allele.
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Figure 5. SpeG spermine-acetyltransferase activity is required for USA300 spermine-resistance
Growth of USA300 in the presence of 5 mM Spermine requires speG and can be inhibited
by the addition of 10 µM Berenil, a spermine/spermidine acetyltransferase inhibitor. This
concentration of Berenil had negligible effects on the growth of USA300 in the absence of
spermine.
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Table 1
Lack of de novo polyamine synthesis in S. aureus.
Organism(Strain) Agmatine Putrescine Cadaverine Spermidine
E. coli (MG1655) 50.0±(5.2) 94.7±(5.3) N.D. 90.7±(11.2)
P. aeruginosa (PA14) N.D. 51.2±(4.7) 20.8±(7.2) 72.6±(8.0)
B. subtilis (168) 15.2±(0.7) 3.2±(0.9) N.D. 428.8±(8.1)
S. aureus (COL) N.D. N.D. N.D. N.D.
S. aureus (USA300) N.D. N.D. N.D. N.D.
·
Values represent mean polyamine levels (nmol) detected per 1010 cfu of indicated organism ± (S.D.), n ≥ 3.
·
N.D. = Not Detected
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Table 2
Minimum Inhibitory and Bactericidal Concentrations of Spermine a
S. aureus strain Aerobic Anaerobic Anaerobic + NO3−
COL 2 (3) 5 (10) 5
COL menD::ErR 4 (5) 10 (15) ND
Newman 3 (3) 7.5 (10) 8
Newman menD::ErR 5 (6) 13 (>15) ND
a
MIC(MBC) mM, error was < 10% of listed values for all measurement
ND: Not Determined
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